Patents Examined by Howard R. Schain
  • Patent number: 5288853
    Abstract: There is provided in accordance with the practice of this invention a process for separating Factor VIII complex from an impure protein fraction containing Factor VIII complex. An aqueous solution of the impure protein fraction containing Factor VIII complex is applied to a heparin-coupled chromatographic medium, to bind the Factor VIII complex to the medium. The Factor VIII is then recovered from the heparin-coupled chromatographic medium by elution with an aqueous solution comprising CaCl.sub.2 and histidine. The recovered Factor VIII is further purified by precipitation with a solution comprising glycine and NaCl, and washing the resultant precipitate with a solution comprising histidine, glycine, and NaCl to provide a Factor VIII complex solution with a specific activity of about 70 to about 150 units/mg.
    Type: Grant
    Filed: April 30, 1992
    Date of Patent: February 22, 1994
    Assignee: Alpha Therapeutic Corporation
    Inventors: Prabir Bhattacharva, Toshiharu Motokubota